David Kerr, CBE MA MD DSc FRCP FRCGP FMedSci
Professor of Cancer Medicine, University of Oxford; Adjunct Prof of Medicine, Weill-Cornell, New York, Honorary Professor of Oncology, Sichuan, Suchow, Xiamen and 2nd Military Universities, China, Honorary Professor, Seoul National University, Korea
Internationally recognized researcher in colorectal cancer care and research. Published over 350 papers, authored over 20 books; awarded 4 prestigious, international research prizes, including the NHS’s first Nye Bevan award for Innovation. Fellow of Academy of Medical Sciences in 2000; awarded CBE by HM The Queen for services to cancer.
President of the European society of Medical Oncology (2009-2011) and Founding Fellow of the European Academy of Cancer Sciences (2010).
Built two new Institutes of Cancer Medicine and associated Clinical Centres in Birmingham and Oxford, UK; Established SIDRA, an international center for medicine and research in Qatar, serving on Supreme Health Council.
Built two cancer clinical trial networks: National Translational Cancer Research Network (UK) and IndOx cancer research network (India).
Entrepreneur who has raised $30 million for health related start up companies.
Developed National Health Plans for Qatar, Scotland, Ghana.
Thought leader in healthcare policy and served as Heath Advisor to Prime Ministers David Cameron and Tony Blair in the UK.
A.R. Jazieh, MD, MPH
Professor and Chairman of Department of Oncology at King Saud bin Abdulaziz University for Health Science. Riyadh, KSA.
As first chairman of newly established Oncology Department, Dr. Jazieh grew the department to be one of the top leading cancer center in the region.
Former Professor and Head of the Hematology Oncology Division at University of Cincinnati where he restructured and expanded the division significantly earning him proclamation to the city of Cincinnati by naming a day after him.
Led a state wide project for screening mammography in the state of Arkansas.
Founded and led the MENA-NCCN Coordinating Center, the first outside USA to adapt NCCN guidelines to the region and lead the MEAN NCCN Lung Cancer Guideline Group.
Established and led the Saudi Lung Association and Lung Cancer Academy and the Saudi Lung Cancer Guidelines Committee.
Obtained American Boards in Internal Medicine, Hematology and Oncology and Master Degree in Public Health, Health Education and Communication.
Former member of ASCO International Affair Committee, the IDEA Selection Committee, the Clinical Trial Workshop Committee and Faculty at ASCO University.
Recently published a book entitled: “Foundation of Evidence Based Medicine: Concepts and Principles of Evidence Based Medicine”.
Calum Kerr, BSc,MBA, CMP
Senior NHS healthcare strategist with 30+ years experience, led the Service Redesign Team for a national healthcare organization ,which shaped and implemented its strategic direction. His expertise includes strategic planning, operational modelling, leadership, managing change and organizational culture.
Experience in working closely with UK & Scottish government Health Depts, including high profile Ministerial visits to Botswana, South Africa and Zimbabwe providing consultation on organizational development and operational policies and procedures.
Experienced Executive coach and change agent.
First National (UK) adviser to the Royal College of Surgeons on Pre-hospital Care.
College lecturer in Business Studies and Organisational Psychology.
Co-founder and Executive Director of Cancer Care Commission.
DR Fred Sun MD
Dr. Fred Sun has had a diverse career in health care beginning as a cardiothoracic surgeon at Pennsylvania State University Hershey Medical Center, As Assistant to Department Director of Cardiothoracic surgery at Susquehanna hospital system in Pennsylvania, he co-created systems for quality and safety based on the integration of IT solutions with evidence-based practice, educational systems and advanced bench marking. As a member of PSU International, he became the Deputy Director of International Collaboration Quality and Safety bringing quality and safety into a highly complex medical delivery system.
He continued his career in international health collaboration and healthcare investments, merger and acquisitions in various leading positions for multiple major healthcare enterprises in China
Dr. Sun leads the CCC China team.